[EN] 1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE 1H-PYRROLO[3,2-B]PYRIDINE EN TANT QU'INHIBITEURS IRRÉVERSIBLES DE MUTANT EGFR POUR LE TRAITEMENT DU CANCER
申请人:[en]BAYER AKTIENGESELLSCHAFT
公开号:WO2024028316A1
公开(公告)日:2024-02-08
The present invention relates to 1H-pyrrolo[3,2-b]pyridine derivatives of formula (I) as irreversible inhibitors of mutant EGFR for the treatment of cancer. An exemplary compound is e.g. N-[2-(4-[3-(4-fluorophenyl)-1H-pyrrolo[3,2-b]pyridin-2-yl]pyridin-3-yl}oxy)ethyl]prop-2-enamide (example 1). Pharmacological data of exemplary compounds is provided (AA).